Arthritis medications could reverse COVID lung damage

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.

Superbugs, antibiotic resistance get renewed scrutiny in Congress

Melanie Lawrence doesn’t think she’ll live long enough to see her son graduate college. Lawrence, a patient with cystic fibrosis from Massachusetts, has been on

July 11, 2023

‘Very Clear Signal’ That Survival Improved With Addition of Durvalumab in SCLC

The phase III ADRIATIC trial showed that adding consolidation treatment with durvalumab (Imfinzi) after concurrent chemoradiotherapy significantly improved progression-free and overall survival in patients with

July 9, 2024

American Heart Association launches initiative to improve hypertrophic cardiomyopathy care

An estimated 1 in 500 people in the U.S. are living with hypertrophic cardiomyopathy (HCM) -; the most common inherited heart disease -; and many

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.